Small-duct primary sclerosing cholangitis

Current Gastroenterology Reports

Volumn 11, Issue 1, 2009, Pages 37-41

  Björnsson, Einar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; URSODEOXYCHOLIC ACID;

AUTOIMMUNE HEPATITIS; BILE DUCT CARCINOMA; CHOLANGIOGRAPHY; CLINICAL FEATURE; COMORBIDITY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG RESPONSE; ENTERITIS; HISTOPATHOLOGY; HUMAN; INCIDENCE; LIVER TRANSPLANTATION; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL TIME;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; DISEASE PROGRESSION; HEPATITIS, AUTOIMMUNE; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; PROGNOSIS; RECURRENCE; RISK FACTORS;

EID: 58849092751     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0006-6     Document Type: Review

References (35)

1. Ludwig J, Barham SS, LaRusso NF, et al.: Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981, 1: 632-640.
2. Ludwig J: Small-duct primary sclerosing cholangitis. Semin Liver Dis 1991, 11: 11-17.
3. Wee A, Ludwig J, Coffey RJ Jr, et al.: Hepatobiliary carcinoma associated with primary sclerosing cholangitis and ulcerative colitis. Hum Pathol 1985, 16: 719-726.
4. Ludwig J, Wiesner R, LaRusso NF: Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 1988, 7: 193-199.
5. Khanlou H, Sass D, Rothstein K, et al.: Idiopathic adulthood ductopenia: a case report and review of the literature. Arch Intern Med 2000, 160: 1033-1036.
6. Angulo P, Maor-Kendler Y, Lindor KD: Small-duct primary sclerosing cholangitis: A long-term follow-up study. Hepatology 2002, 35: 1494-1500.
7. Björnsson E, Boberg KM, Cullen S, et al.: Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002, 51: 731-735.
8. Broomé U, Glaumann H, Lindstöm E, et al.: Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002, 36: 586-589.
9. Nikolaidis NL, Giouleme OI, Tziomalos KA, et al.: Small-duct primary sclerosing cholangitis. A single-center seven-year experience. Dig Dis Sci 2005, 50: 324-326.
10. Charatcharoenwitthaya P, Angulo P, Enders FB, Lindor KD: Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis. Hepatology 2008, 47: 133-142.
11. Björnsson E, Olsson R, Bergquist A, et al.: The natural history of small-duct primary sclerosing cholangitis. Gastroenterology 2008, 134: 975-980.
12. Wiesner RH, LaRusso NF, Ludwig J, et al.: Comparison of the clinicopathological features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985, 88: 108-114.
13. Ludwig J, LaRusso NF, Wiesner R: Primary sclerosing cholangitis. In Contemporary Issues in Surgical Pathology: Liver Pathology. Edited by Peters RL, Craig JR. New York: Churchill Livingstone; 1986:193-213.
14. Boberg KM, Aadland E, Jahnsen J, et al.: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998, 33: 99-103.
15. Kingham JG, Kochar N, Gravenor MB: Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom [letter]. Gastroenterology 2004, 126: 1929-1930.
16. Bambha K, Kim WR, Talwalkar J, et al.: Incidence, clinical spectrum, and outcome of primary sclerosing cholangitis in a United States community. Gastroenterology 2003, 125: 1364-1369.
17. Kaplan GG, Laupland KB, Butzner D, et al.: The burden of large and small duct primary sclerosing cholangitis in adults and children: A population-based analysis. Am J Gastroenterol 2007, 102: 1042-1049.
18. Benito de Valle M, Lindkvist B, Sadik R, Bjornsson E: The clinical spectrum and the prognosis of adult patients with primary sclerosing cholangitis in a population based study in Sweden [abstract W1852]. Presented at the 109th Annual Meeting of the AGA Institute. San Diego, CA, USA; May 17-22, 2008.
19. Broomé U, Olsson R, Löodie;f L, et al.: Natural history and prognostic factors in 305 patients with primary sclerosing cholangitis. Gut 1996, 38: 610-615.
20. Takikawa H, Manabe T: Primary sclerosing cholangitis in Japan-analysis of 192 cases. J Gastroenterol 1997, 32: 134-137.
21. Rasmussen HH, Falingborg JF, Mortensen PB, et al.: Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease. Scand J Gastroenterol 1997, 32: 604-610.
22. Czaja AJ: Variant forms of autoimmune hepatitis. Curr Gastroenterol Rep 1999, 1: 63-70.
23. Alvarez F, Berg PA, Bianchi FB, et al.: International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31: 929-938.
24. van Buuren HR, van Hoogstraten HJE, Terkivatan T, et al.: High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 2000, 33: 543-548.
25. Kaya M, Angulo P, Lindor KD: Overlap of autoimmune hepatitis and primary sclerosing cholangitis: An evaluation of a modified scoring system. J Hepatol 2000, 33: 537-542.
26. Olsson R, Glaumann H, Almer S, et al.: High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. Eur J Int Med 2008 (in press).
27. Poupon RE, Balkau B, Eschwege E, et al.: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991, 324: 1548-1554.
28. Lindor KD, Dickson ER, Baldus WP, et al.: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994, 106: 1284-1290.
29. Olsson R, Broomé U, Danielsson A, et al.: Spontaneous course of symptoms in primary sclerosing cholangitis: Relationships with biochemical and histological features. Hepatogastroenterology 1999, 46: 136-141.
30. Aadland E, Schrumpf E, Fausa O, et al.: Primary sclerosing cholangitis: a long term follow-up study. Scand J Gastroenterol 1987, 22: 655-664.
31. Wiesner RH, Grambsch PM, Dickson ER, et al.: Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 1989, 10: 430-436.
32. Farrant JM, Hayllar KM, Wilkinson ML, et al.: Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991, 100: 1710-1717.
33. Okolicsanyi L, Fabris L, Viaggi S, et al.: Primary sclerosing cholangitis: Clinical presentation, natural history and prognostic variables: An Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol 1996, 8: 685-691.
34. Ponsioen CY, Vrouenraets SM, Prawirodirdjo W, et al.: Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002, 51: 562-566.
35. Bergquist A, Broomé U: Clinical features in primary sclerosing cholangitis. Clin Liver Dis 1998, 2: 283-301.